Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2008
10/08/2008CN101282705A Method for enhancing effects of colorants and conditioners
10/08/2008CN101282657A Methods for the use of branched chain amino acids
10/08/2008CN101280296A Trimeresurus albolabris defibrase, preparation thereof and application thereof to pharmacy
10/08/2008CN101280293A Urate oxidase
10/08/2008CN101280021A Engineered protein against shrimp white spot syndrome virus, preparation and use thereof
10/08/2008CN101280012A Exendin-4 active isomer and application thereof
10/08/2008CN101280009A Exendin4 polypeptide fragments
10/08/2008CN101280004A Polypeptide ERC(N5) for specific inhibition of tumor cell and tumor angiogenic blood vessel
10/08/2008CN101280001A Preparation of human SDF-1 alpha, human SDF-1 alpha obtained therefrom and use thereof
10/08/2008CN101279095A Dried composition
10/08/2008CN101279094A Treatment of T-cell mediated diseases
10/08/2008CN101279091A Pancreatic enzymes enteric coated pellets and preparation
10/08/2008CN101279090A Method for extracting cacti SOD by combination of direct extraction and ultrasonic extraction
10/08/2008CN101279089A Donkey-hide gelatin calcium composition and preparing process thereof
10/08/2008CN100424175C Methods and compositions for treating neoplasms by ERBB3
10/08/2008CN100424172C Oriented mutant gene engineering barr kinase and its use
10/08/2008CN100424171C High purity venom fibrinolysin prepartion method and its pharmaceutical formulation
10/08/2008CN100424096C Survivin mutant containing HIV transduction structural area and its preparation method and uses
10/08/2008CN100424093C Peptides which can bind to transforming growth factor beta 1 (tgf-beta1)
10/08/2008CN100423781C Application of Resistin binding polypeptide for preparing medicine promoting insulin secretion
10/08/2008CN100423777C Glycoprotein compositions
10/08/2008CN100423773C Application of edestin in preparation of medicament
10/08/2008CN100423772C Stabilization of pharmaceutical protein formulations with small peptides
10/08/2008CN100423721C Thrombopoietin mimetics
10/07/2008USRE40535 Light and heavy chains of given amino acid sequence; bind to antigen; radiolabeled; adminstration for diagnosis and treatment of cancer
10/07/2008US7433788 Crystallization of IGF-1
10/07/2008US7432367 Diagnosis of diseases related to an alteration in the regulation or in the coding regions of the RBP-7 gene and for prognosis/diagnosis of an eventual treatment with agents acting on pathologies involving abnormal cell proliferation and/or abnormal cell differentiation.
10/07/2008US7432366 Moraxella catarrhalis BASB034 polypeptides and used thereof
10/07/2008US7432363 Ly6H gene
10/07/2008US7432361 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis
10/07/2008US7432360 Containing 0.001 to 0.01% w/v benzethonium chloride and 0.01 to 0.5% w/v phenoxyethanol or 0.01 to 0.5% w/v phenylethyl alcohol as preservatives; vials for parenteral administration
10/07/2008US7432355 identifying an agent that reduces the lipid binding activity of an apoE stable folding intermediate, the method comprising by contacting an apoE stable folding intermediate in a solution with a test agent and determining the effect
10/07/2008US7432352 Hybrid molecules having Factor VII/VIIa activity
10/07/2008US7432350 Recombinant biotin carboxylase domains for identification of Acetyle CoA carboxylase inhibitors
10/07/2008US7432345 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
10/07/2008US7432344 Porcine CTLA-4 for xenograft-specific immunosuppression
10/07/2008US7432343 MAIL: Molecule possessing Ankyrin repeats Induced by Lipopolysaccharide or I theta B-zeta; antigenic peptide; detection and treatment of carcinomas, especially metastatic breast cancer
10/07/2008US7432341 A decapeptide: EATVGERVRL, which is a non-competitive extracellular cytokine receptor antagonist; decreases vascular endothelial growth factor-induced neovascularization; treating inflammatory, autoimmune and vascular diseases.
10/07/2008US7432308 Therapeutic compositions for the treatment of a respiratory tract disease
10/07/2008US7432301 Use of S-nitrosothiol signaling to treat disordered control of breathing
10/07/2008US7432253 Phosphoepoxides, method for making same and uses
10/07/2008US7432250 Oligoribonucleotides and ribonucleases for cleaving RNA
10/07/2008US7432249 Oligoribonucleotides and ribonucleases for cleaving RNA
10/07/2008US7432245 Pharmaceutical formulation comprising a peptide angiogenesis inhibitor
10/07/2008US7432244 Administering peptides useful in treating disorders caused or mediated by insulin-like growth factors, such as cancer, diabetic complications, acromegaly, age-related macular degeneration, ischemic injuries, or traumas
10/07/2008US7432243 A nucleic acid molecule that encodes at least one polypeptide useful as antiangiogenic, tumor suppressive and antimigratory agent
10/07/2008US7432242 Inhibitors of RGS proteins
10/07/2008US7432241 Site-specific enhancing of coronary collateral development of a diabetic patient by implanting a composite supported vascular graft containing an angiogenesis factor such as Vascular Endothelial Growth Factor; cells are stimulated to migrate to environments having higher concentration of growth factors
10/07/2008US7432240 Fumaric acid amides
10/07/2008US7432239 Polyoxyalkylene compound and method for making
10/07/2008US7432237 Methods of treating asthma by administering interleukin-17 receptor
10/07/2008US7432236 Vasostatin as marrow protectant
10/07/2008US7432098 Polypeptide of given sequence encoding signal peptide; thermal stability; improves nutritional value of foodstuffs
10/07/2008US7432097 Phytases, nucleic acids encoding them and methods of making and using them
10/07/2008US7432077 High-affinity choline transporter
10/07/2008US7432065 Microarray for identifying regulator peptides which bind and regulate modular protein domain (PDZ) interactions with hematopoietic cells for use in treatment of autoimmune, cell proliferative and nervous system disorders; peptide mimetics
10/07/2008US7432061 Assays for measuring matrix metalloproteinase activities
10/07/2008US7432051 Detecting solid breast tumor by measuring polypeptide or mRNA from sample; administering an antagonist to inhibit cell proliferation
10/07/2008US7432045 Membrane transiting peptides having antiviral properties; respiratory disorders
10/07/2008US7431940 Methods for treatment of human skin damaged by laser treatment or chemical peelings and compositions useful in such methods
10/07/2008US7431936 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection
10/07/2008US7431935 Clostridium botulinum neurotoxin for treating spasticity associated with brain ischemia, or traumatic injury of the brain or spinal cord, tension hedache or pain and disorders associated with excessive release of acetylcholine for neuronal tissues
10/07/2008US7431934 Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via same
10/07/2008US7431924 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunizing animal
10/07/2008US7431922 Bioadhesive directed somatic cell therapy
10/07/2008US7431921 Interferon beta-like molecules
10/07/2008US7431920 Method of treating IL-10 deficiency
10/07/2008CA2444071C Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
10/07/2008CA2399464C Drug delivery apparatus
10/07/2008CA2388910C Antimicrobial activity of the first cationic cluster of human lactoferrin
10/07/2008CA2350834C N-terminally truncated her-2/neu protein as a cancer prognostic indicator
10/07/2008CA2264496C Fungal antigens and process for producing the same
10/07/2008CA2250219C Materials and methods for making improved liposome compositions
10/07/2008CA2223449C Peptides and compounds that bind to the thrombopoietin receptor
10/07/2008CA2218515C Monoclonal antibodies against hiv-1 and vaccines made thereof
10/07/2008CA2209426C Human pak65
10/07/2008CA2173956C Dna encoding 1,3-beta-d glucan synthase subunits
10/07/2008CA2148563C Purified nontypable haemophilus influenzae p5 protein as a vaccine for nontypable haemophilus influenzae strain
10/07/2008CA2127317C Method of producing sustained-release preparation
10/07/2008CA2106061C Human follicle stimulating hormone receptor
10/07/2008CA2087494C Soluble ldl receptor, its production and use
10/05/2008CA2583999A1 Characterization of a mekk binding site and uses thereof
10/02/2008WO2008118848A1 N-substituted peptidomimetic inhibitors of dipeptidylpeptidase iv
10/02/2008WO2008118847A1 Composition and method for treating cancer
10/02/2008WO2008118792A2 Gamma delta t cells and methods of treatment of interleukin-17 related conditions
10/02/2008WO2008118784A1 Glycopeptide and lipoglycopeptide antibiotics with improved solubility
10/02/2008WO2008118736A1 Combined human il- 18 and anti cd20 antibody cancer treatment
10/02/2008WO2008118733A2 Methods of treating cancer by administering human il-18 combinations
10/02/2008WO2008118711A2 Method of inhibiting complement activation with human anti-factor c3 antibodies and use thereof
10/02/2008WO2008118507A2 Recombinant human factor ix and use thereof
10/02/2008WO2008118387A2 Erythrocyte atp-release modulators
10/02/2008WO2008118370A2 Hyperbaric treatment in wound healing
10/02/2008WO2008118369A2 Methods for inducing a natural killer (nk) cell-mediated immune response and for increasing nk cell activity
10/02/2008WO2008118350A1 Compositions and methods of using crmp-1 and its fragments for treating cancer
10/02/2008WO2008118148A2 Adiponectin for the treatment and diagnosis of albuminuria
10/02/2008WO2008118093A1 Fusion protein capable of degrading amyloid beta peptide
10/02/2008WO2008117971A1 Use of inhibitors of leukotriene b4 receptor blt2 for treating asthma
10/02/2008WO2008117746A1 Solid fibrinogen preparation
10/02/2008WO2008117735A1 Method for producing soluble thrombomodulin of high purity
10/02/2008WO2008117730A1 Composition for preventing or treating lung disease